This is consistent with our observation that the strongest predictors of NAFLD are markers of liver function (AST/ALT or ALT) and insulin sensitivity (insulin or HOMA-IR). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.